CRLX101 Plus Bevacizumab in Advanced RCC
|2||Active, not recruiting||
A Phase 2 Study of CRLX101 in Patients With Advanced Non-Small Cell Lung Cancer
Study of CRLX101 (Formerly Named IT-101) in the Treatment of Advanced Solid Tumors
Efficacy Study of Maintenance Therapy for Ovarian Cancer Patients
Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.
† Indicates status has not been verified in more than two years